Regulation of ERK1/2 activity upon contact inhibition in fibroblasts

Biochemical and Biophysical Research Communications

Volumn 406, Issue 3, 2011, Pages 483-487

  Küppers, Monika ^a   Faust, Dagmar ^a   Linz, Berenike ^a   Dietrich, Cornelia ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Contact inhibition; Epidermal growth factor receptor; ERK1 2; Fibroblasts; Platelet derived growth factor receptor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN SHC; SHCA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DENSITY; CONTACT INHIBITION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; FIBROBLAST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

ANIMALS; CELL COMMUNICATION; CELL PROLIFERATION; DOWN-REGULATION; FIBROBLASTS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NIH 3T3 CELLS; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR;

EID: 79952739626     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.02.080     Document Type: Article

References (30)

1. Eagle H., Levine E. Growth regulatory effects of cellular interaction. Nature 1967, 213:1102-1106.
2. Zeng Q., Hong W. The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals. Cancer Cell 2008, 13:188-192.
3. Seluanov A., Hine C., Azpurua J., Feigenson M., Bozzella M., Mao Z., Catania K.C., Gorbunova V. Hypersensitivity to contact inhibition provides a clue to cancer resistance of naked mole-rat. Proc. Natl. Acad. Sci. USA 2010, 106:19352-19357.
4. Abercrombie M. Contact inhibition and malignancy. Nature 1979, 281:259-262.
5. Küppers M., Ittrich C., Faust D., Dietrich C. The transcriptional programme of contact- inhibition. J. Cell. Biochem. 2010, 110:1234-1243.
6. INK4 mediates contact inhibition of growth. Oncogene 1999, 18:277-281.
7. Dietrich C., Wallenfang K., Oesch F., Wieser R. Differences in the mechanisms of growth control in contact-inhibited and serum-deprived human fibroblasts. Oncogene 1997, 15:2743-2747.
8. Polyak K., Kato J.Y., Solomon M.J., Sherr C.J., Massague J., Roberts J.M., Koff A. P27KIP1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 1994, 8:9-22.
9. Faust D., Dolado I., Cuadrado A., Oesch F., Weiss C., Nebreda A.R., Dietrich C. P38a MAPK is required for contact inhibition. Oncogene 2005, 24:7941-7945.
10. Pouysségur J., Volmat V., Lenormand P. Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Biochem. Pharmacol. 2002, 64:755-763.
11. Vinals F., Pouysségur J. Confluence of vascular endothelial cells induces cell cycle exit by inhibiting p42/p44 mitogen-activated protein kinase activity. Mol. Cell. Biol. 1999, 19:2763-2772.
12. Wayne J., Sielski J., Rizvi A., Georges K., Hutter D. ERK regulation upon contact inhibition in fibroblasts. Mol. Cell. Biochem. 2006, 286:181-189.
13. Rizzino A., Kazakoff P., Nebelsick J. Density-induced down regulation of epidermal growth factor receptors. In vitro Cell Dev. Biol. 1990, 26:537-542.
14. Swat A., Dolado I., Rojas J.M., Nebreda A.R. Cell density-dependent inhibition of epidermal growth factor receptor signaling by p38alpha mitogen-activated protein kinase via Sprouty2 downregulation. Mol. Cell. Biol. 2009, 29:3332-3343.
15. Rizzino A., Kazakoff P., Ruff E., Kuszynski C., Nebelsick J. Regulatory effects of cell density on the binding of transforming growth factor beta, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor. Cancer Res. 1988, 48:4266-4271.
16. Takahashi K., Suzuki K. Density-dependent inhibition of growth involves prevention of EGF receptor activation by E-cadherin-mediated cell-cell adhesion. Exp. Cell Res. 1996, 226:214-222.
17. Kazlauskas A., DiCorleto P.E. A comparison of the platelet-derived growth factor-dependent tyrosine kinase activity in sparse and confluent fibroblasts. J. Cell. Physiol. 1986, 126:225-236.
18. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 1985, 150:76-85.
19. Zwick E., Hackel P.O., Prenzel N., Ullrich A. The EGF receptor as central transducer of heterologous signalling systems. TiPS 1999, 20:408-412.
20. Courtneidge S.A. Role of Src in signal transduction pathways. The Jubilee Lecture. Biochem. Soc. Trans. 2002, 30:11-17.
21. Malumbres M., Barbacid M. Mammalian cyclin-dependent kinases. Trends Biochem. Sci. 2005, 30:630-641.
22. Brondello J.M., Brunet A., Pouysségur J., McKenzie F.R. The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44MAPK cascade. J. Biol. Chem. 1997, 272:1368-1376.
23. Heit I., Wieser R., Herget T., Faust D., Borchert-Stuhlträger M., Oesch F., Dietrich C. Involvement of PKCδ in contact-dependent inhibition of growth in human and murine fibroblasts. Oncogene 2001, 20:5143-5154.
24. Nelson P.J., Daniel T.O. Emerging targets: molecular mechanisms of cell contact-mediated growth control. Kidney Int. 2002, 61(Suppl. 1):S99-105.
25. Östman A., Yang Q., Tonks N.K. Expression of DEP-1, a receptor-like protein-tyrosine-phosphatase, is enhanced with increasing cell density. Proc. Natl. Acad. Sci. USA 1994, 11:9680-9684.
26. Sacco F., Tinti M., Palma A., Ferrari E., Nardozza A.P., Hooft van Huijsduijnen R., Takahashi T., Castagnoli L., Cesareni G. Tumor suppressor density-enhanced phosphatase-1 (DEP-1) inhibits the RAS pathway by direct dephosphorylation of ERK1/2 kinases. J. Biol. Chem. 2009, 284:22048-22058.
27. Mason J.M., Morrison D.J., Basson M.A., Licht J.D. Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. TiCB 2006, 16:45-54.
28. Kajita M., Ikeda W., Tamaru Y., Takai Y. Regulation of platelet-derived growth factor induced Ras signaling by poliovirus receptor Necl-5 and negative growth regulator Sprouty2. Genes Cells 2007, 12:345-357.
29. Gu J., Tamura M., Yamada K.M. Tumor suppressor PTEN inhibits integrin-and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. J. Cell Biol. 1998, 143:1375-1383.
30. Faisal A., El-Shemerly M., Hess D., Nagamine Y. Serine/Threonine phosphorylation of ShcA regulation of protein-tyrosine phosphatase-pest binding and involvement of insulin signaling. J. Biol. Chem. 2002, 277:30144-30152.